ArticleMedical oncology (Northwood, London, England)2026

Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathway.

Juan Nie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.